Abstract
A series of 50 gastric endocrine tumors classified according to Rindi et al. [1] comprised 12 small cell neuroendocrine carcinomas (NEC) and 38 ECL cell carcinoids, of which 22 associated with type A chronic atrophic gastritis (A-CAG), eight with hypertrophic gastropathy due to combined Multiple Endocrine Neoplasia and Zollinger/Ellison syndrome (MEN/ZES), and eight sporadic. Variables found to predict tumor malignancy were: size > 2 cm, > 2 mitoses and > 130 Ki67 positive cells/10 high power fields (HPF), grade 2 or 3 histology, angioinvasion, p53 protein nuclear accumulation, and the presence of a single tumor. None of these factors increased significantly the predicting ability of tumor classification itself, although grade 2 + 3 shows 100 percent negative predictive value and Ki67 and angioinvasion 100 percent positive predictive value. When the mostly non-malignant A-CAG and MEN-ZES tumors were analysed against the mostly malignant sporadic and NEC tumors, a positive predictive value of 90 percent and a negative predictive value of 93 percent was obtained. Investigation of a larger tumor series is under way with the aim to develop an optimal model for prognostic evaluation of gastric endocrine tumors.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Capella C., Heitz P. U., Höfler H., Solcia E., Klöppel G. Revised classification of neuroendocrine tumours of the lung, pancreas and gut. Virchows Arch. 1995;425(6):547–560. doi: 10.1007/BF00199342. [DOI] [PubMed] [Google Scholar]
- Klöppel G., Heitz P. U. Pancreatic endocrine tumors. Pathol Res Pract. 1988 Apr;183(2):155–168. doi: 10.1016/S0344-0338(88)80043-8. [DOI] [PubMed] [Google Scholar]
- La Rosa S., Sessa F., Capella C., Riva C., Leone B. E., Klersy C., Rindi G., Solcia E. Prognostic criteria in nonfunctioning pancreatic endocrine tumours. Virchows Arch. 1996 Dec;429(6):323–333. doi: 10.1007/BF00198436. [DOI] [PubMed] [Google Scholar]
- Mizuma K., Shibuya H., Totsuka M., Hayasaka H. Carcinoid of the stomach: a case report and review of 100 cases reported in Japan. Ann Chir Gynaecol. 1983;72(1):23–27. [PubMed] [Google Scholar]
- Rappel S., Altendorf-Hofmann A., Stolte M. Prognosis of gastric carcinoid tumours. Digestion. 1995;56(6):455–462. doi: 10.1159/000201276. [DOI] [PubMed] [Google Scholar]
- Rappel S., Rindi G., Bordi C., Capella C., Solcia E., Altendorf-Hofmann A., Stolte M. Karzinoid-Tumoren des Magens bei atrophischer Autoimmungastritis: Klassifikation, Differentialdiagnose und Prognose. Verh Dtsch Ges Pathol. 1996;80:199–207. [PubMed] [Google Scholar]
- Rindi G., Bordi C., Rappel S., La Rosa S., Stolte M., Solcia E. Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology, and behavior. World J Surg. 1996 Feb;20(2):168–172. doi: 10.1007/s002689900026. [DOI] [PubMed] [Google Scholar]
- Rindi G., Buffa R., Sessa F., Tortora O., Solcia E. Chromogranin A, B and C immunoreactivities of mammalian endocrine cells. Distribution, distinction from costored hormones/prohormones and relationship with the argyrophil component of secretory granules. Histochemistry. 1986;85(1):19–28. doi: 10.1007/BF00508649. [DOI] [PubMed] [Google Scholar]
- Rindi G., Luinetti O., Cornaggia M., Capella C., Solcia E. Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: a clinicopathologic study. Gastroenterology. 1993 Apr;104(4):994–1006. doi: 10.1016/0016-5085(93)90266-f. [DOI] [PubMed] [Google Scholar]
- Solcia E., Capella C., Sessa F., Rindi G., Cornaggia M., Riva C., Villani L. Gastric carcinoids and related endocrine growths. Digestion. 1986;35 (Suppl 1):3–22. doi: 10.1159/000199378. [DOI] [PubMed] [Google Scholar]
- Wilander E., El-Salhy M., Pitkänen P. Histopathology of gastric carcinoids: a survey of 42 cases. Histopathology. 1984 Mar;8(2):183–193. doi: 10.1111/j.1365-2559.1984.tb02335.x. [DOI] [PubMed] [Google Scholar]